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Wnt signaling, BMP pathwayObesity has been reported as an independent risk factor for chronic kidney disease, leading to glomerulosclerosis
and renal insufﬁciency. To assess the relationship between a reduced nephron number and a particular suscep-
tibility to obesity-induced renal damage, mice underwent uninephrectomy (UNX) followed by either normal
chow or high-fat diet (HFD) and were compared with sham-operated control mice. After 20 weeks of dietary
intervention, HFD-fed controlmice presented characteristic features of progressive nephropathy, including albu-
minuria, glomerulosclerosis, renalﬁbrosis and oxidative stress. These changesweremorepronounced inHFD-fed
mice that had undergone uninephrectomy. Analysis of gene expression in mouse kidney by whole genome mi-
croarrays indicated that high fat diet led tomore changes in gene expression than uninephrectomy. HFD affected
mainly genes involved in lipidmetabolism and transport, whereas the combination of UNX and HFD additionally
altered the expression of genes belonging to cytoskeleton remodeling, ﬁbrosis and hypoxia pathways. Canonical
pathway analyses identiﬁed the farnesoid X receptor (FXR) as a potential keymediator for the observed changes
in gene expression associated with UNX-HFD. In conclusion, HFD-induced kidney damage is more pronounced
following uninephrectomy and is associated with changes in gene expression that implicate FXR as a central
regulatory pathway.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Obesity is not only associated with an increase in morbidity, mortal-
ity and reduction in life expectancy, but also leads to an increase in the
incidence of diabetes, hypertension and dyslipidemia [1,2]. Further-
more, obesity is now being increasingly recognized as a major and
independent risk factor for the development of chronic kidney disease
(CKD) [3,4], focal glomerulosclerosis [5], and end stage renal disease
(ESRD) [6–9]. Recent observational studies demonstrate that obesity isdiet; FXR, farnesoid X receptor;
rting polypeptide; OAT, organic
y; Abc, ATP-binding cassette
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. This is an open access article underan independent risk factor for CKD in patients with reduced renal
mass [6,9]. Currently, a growing population lives with reduced renal
mass considering the higher rates of primary kidney tumor in adults
and congenital solitary kidney in children, as well as the rising number
of living kidney donors [10–13]. Given the epidemics of overweight in
the U.S. and worldwide [14,15], the number of obese people with
reduced renal mass is expected to increase. Despite the public health
and clinical implications of the relationships between obesity and
kidney injury in patients that have undergone nephrectomy [6,9], the
mechanisms leading to obesity-induced renal damage in reduced
renal mass are less clear.
To date, clinical and experimental studies have shown that the char-
acteristic features of obesity induced kidney injury [16,17] contribute to
albuminuria, a progressive decline in renal function and ultimately
glomerulosclerosis and tubulointerstitial ﬁbrosis [18–22]. Since chronic
kidney disease is a complex kidney disease, interruption of a single
pathway is unlikely to result in a signiﬁcant therapeutic beneﬁt. Further
understanding of the pathogenesis of renal failure thus requires global
expression analysis of disease states using genomics and/or proteomics
tools [23–27].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Baseline characteristics of the different treatment groups.
Sham UNX
Chow HFD Chow HFD
Body weight (g) 35.5 ± 0.6 53.2 ± 1.5a 33.7 ± 0.8 47.5 ± 3.1a
Kidney weight
(mg)
215.0 ± 9.0 235.8 ± 8.9 272.0 ± 11.5b 277.6 ± 12.8b
Plasma TG
(mg/dl)
97.0 ± 14.0 139.6 ± 12.1a 102.1 ± 7.7 148.6 ± 9.3a
Plasma Ch
(mg/dl)
115.8 ± 14.8 198.2 ± 4.1a 109.4 ± 5.8 177.9 ± 15.5a
Abbreviations: UNX, uninephrectomy; HFD, high fat diet. n = 6 mice/group.
a p b 0.05, comparison between chow and HFD.
b p b 0.05, comparison between sham and UNX.
1871Z. Gai et al. / Biochimica et Biophysica Acta 1842 (2014) 1870–1878In this study, high-fat-diet-fed mice were used as an obesity model.
We examined the kidney function and histological changes of 20-week
uninephrectomized (UNX) mice fed with a chow diet (UNX-chow),
UNX mice fed with a high fat diet (UNX-HFD) and sham-operated
control mice (sham-chow and sham-HFD). Gene expression in kidney
tissue of these four groups was also analyzed to better comprehend
the molecular mechanisms underlying advanced renal disease and the
pathogenetic role of obesity in the onset of proteinuria and renal
insufﬁciency. UNX-HFD mice presented higher degrees of progressive
nephropathy, albuminuria and renal ﬁbrosis. Moreover, we observed
marked changes in a number of genes and gene families involved in cy-
toskeleton remodeling, ﬁbrosis and lipid metabolism in the UNX-HFD
group and novel pathways linked with farnesoid X receptor (FXR)
signaling that have not been previously associated with renal disease
progression. The altered expression of some of these genes is also
associated with possible protective and compensatory mechanisms.
Additionally, our results indicate that obesity-induced chronic renal
disease is accelerated in UNX.
2. Materials and methods
2.1. Uninephrectomy
Male C57/BJ mice aged 6 weeks were randomly assigned to
uninephrectomy (UNX) or sham procedures and fed with a high fat
diet (D12331; ResearchDiets, NJ, USA) or control chow diet (Provimi
Kliba). Mice were divided into 4 groups of 6: sham-chow, UNX-chow,
sham-HFD and UNX-HFD. For uninephrectomy, mice were initially
anesthetizedwith 3% to 5% isoﬂurane, orally intubated, andmechanical-
ly ventilated. Anesthesia was maintained with 1.5% to 2% isoﬂurane de-
livered in oxygen. The left kidney was surgically removed via a left
paramedian incision on the back. The adrenal gland was carefully
freed from the upper pole of the renal capsule before the renal pedicle
was ligated and the kidney removed. For sham surgery, the kidney
wasmanipulatedwithout ablation. All micewere sacriﬁced under anes-
thesia 20 weeks after surgery and kidneys were harvested. Half of the
kidney from each animal was snap frozen in liquid nitrogen and stored
at−80 °C for RNA and protein extraction. The other half was ﬁxedwith
formalin for histology. All protocols conformed to the Swiss animal
protection laws and were approved by the Cantonal Veterinary Ofﬁce
in Zurich, Switzerland.
2.2. Measurement of plasma and urine samples
For 24-h urine collection, individual mice were placed in metabolic
cages with access to diets. Urinary albumin and creatinine concentra-
tions were measured with the Albumin mouse ELISA kit (ab108792,
Abcam, Cambridge, UK) and Creatinine assay kit (ab65340, Abcam,
Cambridge, UK). Urinary H2O2 levels were measured using the Amplex
Red H2O2 assay kit (A12214, Invitrogen, CA, US). Plasma samples were
obtained from tail blood of fasted mice. Plasma cholesterol and triglyc-
eride levels were measured by the Amplex Red cholesterol assay kit
(A12216, Invitrogen, CA, US) and theTriglyceride assay kit (ETGA-200,
EnzyChrom, Aachen, Germany), respectively.
2.3. Assessment of renal pathology and immunostaining
Kidneys were ﬁxed overnight in 10% neutral buffer formalin and
embedded in parafﬁn. Tissue sections were cut at 3 μm and stained for
hematoxylin and eosin, periodic acid-Schiff (PAS) and Masson's
trichrome using standard protocols. Mesangial area was determined
fromPAS stained sections andﬁbrotic areawas assessed from trichrome
stained sections as described [28,29]. Brieﬂy, digital images of random
high power ﬁelds were analyzed by a blind observer. The cross-
sectional area of the glomerulus or area of ﬁbrosis was determined by
using the program Adobe Photoshop. 4 mice were analyzed per group.Immunostainingwas performed on parafﬁn sections using amicrowave
based antigen retrieval technique. The antibodies used in this study in-
cluded Actn1 (Novus biologicals, Cambridge, UK), Slc27a4 (Proteintech,
Manchester, UK), TNFα (Abcam, Cambridge, UK) and Cyp4a (Santa
Cruz, CA, US). The antibody against Slco1a1 was previously raised in
our group (Dr. Bruno Stieger). Sectionswere treatedwith the Envision+
DAB kit (Dako, Denmark) according to the manufacturer's instruction.2.4. Microarray and gene expression analysis
RNAwas extracted from frozen kidney using RNeasyMicroarray Tis-
sue mini kit (73304, Qiagen, Germany), followed by on column DNase
digestion to remove any contaminating genomic DNA. RNA samples
from 4 mice per group were subjected to microarray analysis. Brieﬂy,
100 ng of total RNA was reverse-transcribed into double-stranded
cDNA, which was linearly ampliﬁed and labeled with Cy3 dye. Follow-
ing quantiﬁcation using a Nanodrop spectrophotometer (Witec, Luzern,
Switzerland) and quality assessment with Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA), 1.6 μg of the obtained Cy3-
labeled cRNA was hybridized to Mouse GE 4x44K v2 Microarrays
(Agilent Technologies, Santa Clara, CA) according to the manufacturer's
protocol. Arrays were scanned with an Agilent G2565CA Microarray
Scanner System (Agilent, Santa Clara, CA). Raw intensity data were ob-
tained using Agilent's Feature Extraction Software version 10.7 for array
image analysis and the calculation of spot intensitymeasurements. Data
analysis was carried out with R/Bioconductor. The processed intensities
and normalized across samples were loaded by using quantile normal-
ization. All microarray data was submitted to the Gene Expression
Omnibus (accession number GSE53996). Differential expression was
computed using the limma package. More details on analysis methods
can be found at http://fgcz-bfabric.uzh.ch/wiki/tiki-index.php?page=
app.two_groups. Gene ontology analysis, network analysis and canoni-
cal pathway analysis of the microarray data were completed using the
Ingenuity Pathway Analysis (Qiagen, Redwood, CA) software, MetaCore
online service (Thomson Reuters), and Subio platform (Subio Inc,
Kagoshima, Japan).2.5. Semi-quantitative RT–PCR
Validation of microarray data was performed for selected differen-
tially expressed genes by sqRT–PCR. Brieﬂy, 2 μg total RNA (n = 3 to
4), from the same samples sent for microarray, was reverse transcribed
using oligo-dT priming and SuperscriptII (Invitrogen, CA, US). First-
strand complementary DNA was used as the template for real-time
polymerase chain reaction analysis with TaqMan master mix and
primers (Applied Biosystems, CA, US). Transcript levels, determined in
two independent complementary DNA preparations, were calculated
as described and expressed relative to villin as housekeeping gene.
Fig. 1. Albuminuria and urinary H2O2 output in the four treatment groups. (A) Urine albumin/creatinine ratio increases with HFD at 20 weeks. (B) Urine H2O2/creatinine level is increased
in mice fed with HFD for 20 weeks. Data are shown as mean ± SEM, *p b 0.05.
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Data are expressed asmean±SEM. Formicroarray data, comparison
was assessed by Student's t test with R/Bioconductor to generateFig. 2. Histological analysis of remnant kidney tissue. Histological appearance of glomeruli in
Representative images of (E to H) Masson trichrome-stained and (I to L) PAS stained renal sec
sham-HFD mice and (H and L) UNX-HFD mice. (M and N) Bars represent the quantitative ana
mean ± SEM, *p b 0.05.differentially expressed genes (UNX-chow vs. sham-chow; UNX-HFD
vs. sham-HFD; sham-HFD vs. sham-chow; UNX-HFD vs. UNX-chow).
For other data regarding baseline characteristic analysis and histological
analysis, comparison between groups was assessed by one-way ANOVA(A) sham-chow mice, (B) UNX-chow mice, (C) sham-HFD mice and (D) UNX-HFD mice.
tions of kidney tissues of (E and I) sham-chow mice, (F and J) UNX-chow mice, (G and K)
lysis of (M) area of ﬁbrosis and (N) area of mesangium where data are expressed as the
Fig. 3.Microarray analysis of mRNA expression levels in kidney tissue of the four treat-
ment groups. (A) Summary of differentially expressed genes between groups. Cut off
1.7-fold, p b 0.05. (B) Plot sources of variation analysis indicate diet as the factor with
the higher impact on gene expression among those four groups. Error indicates no impact
on gene expression. Data were analyzed using Subio platform software.
1873Z. Gai et al. / Biochimica et Biophysica Acta 1842 (2014) 1870–1878followed by Bonferroni's test. Statistical analyses were performed with
GraphPad software.
3. Results
3.1. Systemic metabolic abnormalities
To evaluate the effect of uninephrectomy (UNX) on HFD-induced
renal disease, mice at six weeks of age underwent UNX, followed by
either a normal or high fat diet (HFD) for 20 weeks. The characteristics
of the four groups at 20 weeks of the experimental period are presented
in Table 1. Both sham and UNX mice that consumed HFD showed
markedly increased body weight. The body weight of UNX-chow and
UNX-HFD mice tended to be lower than in their counterparts that had
undergone sham operation, although this difference did not reach
statistical signiﬁcance during the observation period. UNX signiﬁcantly
increased the weight of the remnant kidney, especially in mice fed the
HFD. Mice from the HFD group showed signiﬁcantly higher plasma
triglyceride and cholesterol levels. UNX, however, had no effects on
these biochemical parameters. As shown in Fig. 1, the biochemical anal-
ysis of creatinine and albumin conﬁrmed chronic renal disease progres-
sion in UNX-HFD mice. Sham-operated mice consuming the HFD
developed progressive albuminuria and UNX produced a more striking
increase in the albumin/creatinine ratio in mice fed the HFD at
20 weeks. Moreover, the urinary H2O2 level was also signiﬁcantly
higher in the UNX group after 20 weeks of the high fat diet, indicating
a greater degree of oxidative stress in the UNX-HFD remnant kidney.
3.2. UNX accelerates renal ﬁbrosis and glomerulosclerosis in obese mice
The effect of UNX on the acceleration of ﬁbrosis and glomeru-
losclerosis in obese mice was evident by trichrome and PAS staining.
As shown in Fig. 2, HFD increased ﬁbrosis in sham-operated mice
assessed after 20 weeks of feeding (Fig. 2G). However, kidney sections
from UNX-HFD mice showed the most severe degree of ﬁbrosis
(Fig. 2H). By quantitative analysis (Fig. 2M), interstitialﬁbrosis, as deter-
mined by Trichrome staining, was approximately 2-fold greater in UNX-
HFD kidneys than in sham-HFD kidneys. Furthermore, quantitation
from PAS-stained sections showed that the mesangial matrix content
was increased signiﬁcantly by UNX in HFD kidneys compared with the
sham-operated counterparts (Fig. 2I–L and N).
3.3. Effects of UNX and HFD on gene expression in the kidney
In parallel, global gene expression in the 20-week remnant kidneys
of uninephrectomized mice fed either a chow or a high fat diet was
compared with kidney tissue from the corresponding sham groups.
3–4 total RNA samples per group were analyzed and gene expression
was compared between groups.
First, gene expression was compared between UNX-chow
mice versus sham-chow mice (UNX-chow/sham-chow) and between
UNX-HFD mice versus sham-HFD mice (UNX-HFD/sham-HFD). By
using a≥1.7-fold change as a cut-off, only 157 genes were differentially
expressed between the UNX-chow/sham-chow groups and 136 genes
between the UNX-HFD/sham-HFD groups (Fig. 3A). Analysis of plot
sources of variation conﬁrmed that the impact of the high fat diet was
greater than that of UNX on gene expression in these four groups
(Fig. 3B).
Next, in order to identify genes altered by HFD, the following
datasets were compared: UNX-HFD versus UNX-chow (designated as
UNX dataset) and sham-HFD versus sham-chow (designated as sham
dataset). Comparison of data from sham-HFD versus sham-chow and
data from UNX-HFD versus UNX-chow revealed that 2441 and 2581
genes, respectively, were signiﬁcantly increased or decreased at least
1.7-fold (Fig. 3A, Tables S1 and S2). Interestingly, a substantial number
of genes (1289 genes) overlapped in being differentially expressed inboth theUNX-HFD/UNX-chowand the sham-HFD/sham-chowdatasets,
as shown by Venn diagram analysis (Fig. 4A and Table S3). The over-
lapping genes in both the UNX and sham datasets included genes
involved in lipid transport and metabolism (Fig. 4B). However,
genes implicated in ion transport and in renal hypoxia showed
altered expression only in the UNX-HFD remnant kidneys (Fig. 4C,
Tables 3 and S4). Importantly, the altered expression of genes re-
sponsive to hypoxia (Table 3) is consistent with the increased
urinary H2O2 levels in UNX-HFD mice.
The differences between the two datasetswere further conﬁrmed by
network and canonical pathway analyses. Network analyses with these
two datasets are shown in Fig. 5. The common networks from both
datasets were associated with cell adhesion, inﬂammation and apopto-
sis, whereas networks linked to cytoskeleton remodeling and cell-
matrix adhesionmainly fell into the UNXdataset. Table 2 shows the dis-
crepancies between the canonical pathways in each dataset. The FXR
pathway is the top canonical pathway in the UNX-HFD dataset with
14 genes altered 1.7-fold, whereas only 10 genes are signiﬁcantly
changed in the sham-HFD dataset (Table 3). Several canonical pathways
which relate to ﬁbrogenesis were also shown to be signiﬁcantly
changed in the UNX dataset, including decreased expression of genes
within the BMP pathway and increased expression of genes within the
Wnt signaling pathway (Table 3), which is in line with the histological
observations (Fig. 2H and M).3.4. Validation of microarray ﬁndings with semi-quantitative RT–PCR and
immunostaining
To validate microarray results, we selected 9 FXR-regulated genes in
the UNX dataset and quantiﬁed their expression by real-time PCR. All
Fig. 4. Comparison of common and distinct gene expression patterns across the different experimental conditions. (A) Venn diagram analysis of sham versus UNX datasets indicates that
1289 genes (green) are commonly expressed in both sham-HFD and UNX-HFD kidneys, whereas 1152 and 1292 genes are distinctly expressed in sham-HFD kidneys (blue) or UNX-HFD
kidneys (orange), respectively. Data were analyzed using Subio platform software. (B) Gene ontology (GO) analysis of genes with a change in expression of≥1.7 fold in kidney tissue of
both sham-HFD and UNX-HFDmice. Top 5 GO functional gene clusters aremostly involved in lipid transport andmetabolism (green bars). (C) GO analysis of genes that showed a change
of expression of ≥1.7 fold only in kidney tissue of UNX-HFD mice (orange bars).
1874 Z. Gai et al. / Biochimica et Biophysica Acta 1842 (2014) 1870–1878sqRT–PCR analyses were performed in samples previously used for mi-
croarray experiments. We found that both methods (microarray analy-
sis and sqRT–PCR) yielded similar results regarding the increase and
decrease in gene expression (Fig. 6).
Next,we examined the immunostaining of kidney sectionswith spe-
ciﬁc antibodies against Actn1, Slco1a1, Slc27a4, TNFα and Cyp4a. Fig. 7
shows representative staining images of kidney sections from different
treatment groups. Consistent with the changes in gene expression
shown in Fig. 6 and Table 3, the staining of Actn1 (actinin, a cytoskeletalFig. 5. Network analysis of genes with a change of expression of≥1.7 fold across treatment gro
level in kidneys of both sham-HFD and UNX-HFD mice; genes that show altered expression ex
orange bars, respectively.protein, 3.2-fold increase at themRNA level) was increased in the cyto-
plasm of tubular cells (mostly proximal tubules) in the UNX-HFD group
(Fig. 7A–D); staining of Slc27a4 (fatty acid transporter 4, 1.9-fold in-
crease at the mRNA level) was enhanced in the apical membrane of
proximal tubules (indicated by arrows, Fig. 7I–L); staining of TNFα
(4.35-fold increase at the mRNA level) and Cyp4a14 (2.3-fold increase
at the mRNA level) was increased in the cytoplasm of tubular cells (in-
dicated by arrows, Fig. 7M–P and Q–T, respectively). In contrast, stain-
ing of Slco1a1 (Oatp1a1, organic anion transporter that mediates theups. The top 5 networks are listed. Green bars indicate genes with a change of expression
clusively in kidney tissue of either sham-HFD or UNX-HFD mice are indicated by blue and
Table 2
Top 5 canonical pathways from UNX-HFD dataset.
Top 5 pathways by IPA
(Ingenuity Pathway Analysis)
Top 5 pathways by MetaCoreTM
Name p value Name p value
FXR/RXR activation 3.11E-05 WNT and cytoskeletal remodeling 5.54E-08
LXR/RXR activation 2.86E-03 Neurophysiological process signaling 3.30E-05
Caveolar-mediated endocytosis signaling 4.35E-03 Cytoskeleton remodeling 2.43E-04
Androgen biosynthesis 4.4E-03 Cell-matrix glycoconjugates 1.02E-03
Retinoate biosynthesis 5.26E-03 Fxr regulated cholesterol and bile acid transport 1.62E-03
Differences in gene expression between UNX-HFD and UNX-chow groups were analyzed by IPA (Ingenuity Pathway Analysis) software and MetaCoreTM pathway online analysis.
1875Z. Gai et al. / Biochimica et Biophysica Acta 1842 (2014) 1870–1878reuptake of organic anions, 0.36-fold decrease at mRNA level) was de-
creased in the apicalmembrane of proximal tubules inUNX-HFD kidney
sections (Fig. 7E–H).
4. Discussion
An emerging body of evidence suggests that obesity is not only a risk
factor for CKD, but also an independent cause of renal dysfunction.
Glomerulosclerosis and progressive renal insufﬁciency have been re-
ported in obese patients and experimental animals with a normal
renal mass [5,30]. Therefore, it is conceivable that renal damage due to
obesity-related hyperﬁltration is especially severe in conjunction with
a reduction in renal mass. Studies on the relationship between reduced
nephron number and susceptibility to obesity-related renal damage
have suggested that obesity is associated with higher glomerular
hyperﬁltration [31] and higher risks of proteinuria and CKD [9,32] in
kidney donors. These observations led us to explore the mechanisms
underlying renal insufﬁciency after renal mass reduction. We showed
that obesity has marked effects on proteinuria, glomerular damage
and interstitial ﬁbrosis in mice fed a HFD, and these changes were fur-
ther enhanced by uninephrectomy. Furthermore, geneproﬁling analysis
and functional classiﬁcation of differentially expressed genes in kidneys
from each group revealed the synergistic effects of UNX and HFD on the
expression of genes responsible for cytoskeletalmorphogenesis,ﬁbrosis
and lipid metabolism. As a consequence, the function of the remnant
kidney is more severely impaired.
The gene proﬁling results are partly consistent with other studies
analyzing gene expression in obesity-related glomerulopathy in obese
patients [17]. One important group of genes with a notable change in
expression induced by the high fat diet involved lipid metabolism and
transport, in both sham-HFD and UNX-HFD groups. Disturbances inTable 3
Selected differentially expressed genes (≥1.7 fold) in 20-week remnant kidney of UNX-HFD m
Cytoskeleton remodeling
Actn1 (1.69), Cﬂ1 (1.33), Mmp7 (1.68), Cd44 (0.85), Hrh4 (0.85), Taok2 (1.54), Rap1a (1.9
Wnt signaling induced EMT (pro-ﬁbrosis)
Wnt1 (0.79), Wnt16 (0.98), Trp73 (1.12), Adam17 (1.36), Adam25 (0.81), Lfng (1.59), Act
Lipid metabolism
Abcb4 (−0.97), CYP2B10 (−2.24), CYP2D10 (−2.03), CYP3A59 (−2.35), CYP4A32 (1.16)
(1.34), SLC27A4 (0.95)
Response to hypoxia
Nppa (0.767), Ascl2 (0.8), Hpx (−3.54), Ece1 (0.85), Ccr6 (1.4), Ccr10 (1.07), Ppyr1 (0.95)
(−0.82), Prkd3 (0.82), Pklr (1.51), Ramp1 (0.80), Ucp3 (1.26), Chrnb2 (0.84)
Fxr regulated transporters
Slco1a1 (−1.48), Slco1b2 (−2.53), Slc22a7 (−2.18), Abcb4 (−0.97)
Salt and ﬂuid retention
Cyp4a14 (1.18), Slc4a4 (3.94), Slc9a3 (0.79)
Numbers in parentheses indicate gene expression levels quantiﬁed as Log2 of fold changes: (1lipid metabolism are often observed in patients with chronic renal
failure, and the negative impact of proteinuria on kidney disease
progression could be mediated in part through the increased ﬁltration
of lipoproteins [33]. Network analysis showed thatmore genes involved
in lipid transport and metabolism were affected in obese mice than in
mice fed with the chow diet (Table 3). Furthermore, several other net-
works were identiﬁed to be uniquely expressed in the UNX-HFD
dataset, including cytoskeleton remodeling, cell-matrix adhesion and
other genes involved in ﬁbrogenesis. Thus, our microarray data are
consistent with histological results which indicate that kidneys from
UNX-HFD mice have a higher degree of mesangial matrix content and
interstitial ﬁbrosis.
Pathway analysis implicated the Fxr signaling pathway as showing
the strongest degree of activation in the remaining kidney of UNX-
HFD mice. Fxr plays crucial roles in bile acid, cholesterol, lipid and
glucose metabolism in the liver and intestine. In the liver, Fxr activation
exerts antiﬁbrotic effects by increasing the apoptosis of hepatic stellate
cells [34]. However, the role of Fxr in kidney disease is still unclear. Fxr
activation by potent agonists protects kidney function and limits renal
ﬁbrosis in diabetic and obese mice [35–37]. We previously showed
that incubation of primary cultured rat renal proximal tubular cells
with the FXR ligand chenodeoxycholic acid regulates the expression of
bile acid transporters [38]. Moreover, exposure of hepatoma cells to
bile acids decreased the expression of hOATP1B1 (SLCO1B1) and
hOAT2 (SLC22A7) by an FXR-mediated mechanism [39,40]. Here, we
show decreased renal expression of the orthologous mouse genes
Slco1b2 and Slc22a7 (Fig. 6), suggesting a conserved role of Fxr in regu-
lating bile acid transport in the kidney. However, recent studies on Fxr
null mice with bile duct ligation show that loss of Fxr in fact protects
the kidney from cholemic nephropathy caused by high plasma bile
acids [41]. Future studies on kidney-speciﬁc Fxr knockout mice will beice grouped according to function.
1), Prkd3 (0.82), Tesk2 (0.77), Actg1 (0.98), Tubb3 (1.65), Parva (0.79), Pfn1 (0.94)
n1 (1.69), Actg1 (0.98), Dvl2 (0.96), Mmp7 (1.68)
, Cyp7b1 (−1.15), FOXO4 (1.14), Mup1 (includes others), Nr1i3/Car (0.78), SLC1A6
, Hif3a (1.39), Pklr (1.51), Kcna5 (1.42), Lep (2.63), Lepr (−0.84), P2rx2 (0.84), Pde7b
.69) corresponds to a 3.23 fold and (−2.18) to a 0.22 fold change in gene expression.
Fig. 6. sqRT–PCR validation ofmicroarray data. Changes in the expression level of FXR regulated genes as determined bymicroarray analysis (see Table 3) were reproducible by sqRT–PCR.
Cyp4a14 is shown as a positive control for a HFD-induced increase in gene expression. Numbers shown in italics below gene names indicate the fold change in expression level detected by
microarray (Table 3). Data are shown as mean ± SEM, *p b 0.05.
1876 Z. Gai et al. / Biochimica et Biophysica Acta 1842 (2014) 1870–1878required to deﬁne the exact role of Fxr in obesity-induced kidney
disease.
Whereas some diets commonly used to induce alterations in lipid
homeostasis and/or obesity contain cholic acid to enhance fat absorp-
tion, the high fat diet D12331 used in the present study (formula
shown in Table S5) did not contain bile acids. Thus, the effects on Fxr
signaling seen in the UNX-HFD mice were not induced by external bile
acid administration. UNX-HFD mice had a tendency towards increased
plasma bile acid levels, however this increase did not reach statistical
signiﬁcance by ANOVA analysis (data not shown). Because HFD has
been reported to contribute to a dysfunction of the lysosomal system
and altered lipid metabolism, characterized by cholesterol and phos-
pholipid accumulation in the kidney [42], we also measured kidney
lipid composition in each group by thin layer chromatography. UNX-
HFD kidney tissue had a tendency towards increased total phospholipid
and cholesterol content, although the differences between groups did
not reach statistical signiﬁcance by ANOVA analysis (Supplementary
Fig. 1A–D).
Nephrectomy in man is generally considered to have a favorable
long-term outcome. To what degree a reduced renal mass is safe may
depend, however, on the general health condition [43]. Our study,among various similar studies in a large variety of models for hyperten-
sion, diabetes and kidney disease [29,44,45], illustrates that in a dis-
eased animal (including man), or in an animal model with increased
glomerular capillary pressure, a reduction in renal mass is accompanied
by an acceleration of renal disease. Taking into account the synergistic
effects of obesity and UNX on the progression of renal insufﬁciency,
avoidance ofweight gain or weight loss in obese patients should be rec-
ommended to individuals with reduced renal mass [46–48]. Our results
also have relevance in the setting of kidney donation, which results in a
reduced renal mass and is being performed in an increasingly obese
population [49].
In conclusion, we found that the effects of a HFD on the kidney ap-
pear to be accentuated in mice that have undergone uninephrectomy,
as evidenced by accelerated progression of proteinuria and renal insuf-
ﬁciency 20 weeks after the procedure. This was also conﬁrmed by the
increased mesangial basement membrane area and the degree of
renalﬁbrosis in theUNX-HFDmice.We thus show that uninephrectomy
acts in synergismwith HFD to promote changes in gene expression that
are associated with renal damage and that activation of the FXR signal-
ing pathway could be a protectivemechanism in thismodel of advanced
renal disease.
Fig. 7. Immunohistochemistry staining of remnant kidney tissue for selected targets. Kidney parafﬁn sections from different treatment groups were immunostained with antibodies
against Actn1 (A to D), Slco1a1 (E to H, decreased expression inUNX-HFD), Slc27a4 (I to L), TNFα (M to P) and Cyp4a14 (Q to T). Arrows indicate positive staining shown in representative
images.
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